This company listing is no longer active
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Satsuma Pharmaceuticals マネジメント
マネジメント 基準チェック /24
Satsuma Pharmaceuticals' CEO is John Kollins, appointed in Jul 2016, he has a tenure of 6.92 years. His total yearly compensation is $1.91M , comprised of 27.8% salary and 72.2% bonuses, including company stock and options. He directly owns 0.94% of the company’s shares, worth €317.23K. The average tenure of the management team and the board of directors is 5.9 years and 5.8 years respectively.
主要情報
John Kollins
最高経営責任者
US$1.9m
報酬総額
| CEO給与比率 | 27.8% |
| CEO在任期間 | 6.9yrs |
| CEOの所有権 | 0.9% |
| 経営陣の平均在職期間 | 5.9yrs |
| 取締役会の平均在任期間 | 5.8yrs |
経営陣の近況
Recent updates
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -US$65m |
| Dec 31 2022 | US$2m | US$530k | -US$70m |
| Sep 30 2022 | n/a | n/a | -US$62m |
| Jun 30 2022 | n/a | n/a | -US$61m |
| Mar 31 2022 | n/a | n/a | -US$56m |
| Dec 31 2021 | US$830k | US$500k | -US$51m |
| Sep 30 2021 | n/a | n/a | -US$48m |
| Jun 30 2021 | n/a | n/a | -US$47m |
| Mar 31 2021 | n/a | n/a | -US$46m |
| Dec 31 2020 | US$4m | US$456k | -US$48m |
| Sep 30 2020 | n/a | n/a | -US$46m |
| Jun 30 2020 | n/a | n/a | -US$42m |
| Mar 31 2020 | n/a | n/a | -US$37m |
| Dec 31 2019 | US$1m | US$391k | -US$28m |
| Sep 30 2019 | n/a | n/a | -US$20m |
| Jun 30 2019 | n/a | n/a | -US$13m |
| Mar 31 2019 | n/a | n/a | -US$8m |
| Dec 31 2018 | US$568k | US$362k | -US$7m |
報酬と市場: John's total compensation ($USD1.91M) is above average for companies of similar size in the German market ($USD407.72K).
報酬と収益: John's compensation has increased whilst the company is unprofitable.
CEO（最高経営責任者
John Kollins (60 yo)
6.9yrs
在職期間
US$1,909,812
報酬
Mr. John A. Kollins, MBA, has been Director, President and Chief Executive Officer of Satsuma Pharmaceuticals, Inc since July 2016. He served as Chief Business Officer and Senior Vice President of Transcep...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 6.9yrs | US$1.91m | 0.94% $ 317.2k | |
| Chief Financial Officer | 4.4yrs | US$936.85k | 0.042% $ 14.2k | |
| VP & Head of Operations | 6.4yrs | データなし | データなし | |
| Senior VP & Head of Chemistry | 5.9yrs | データなし | データなし | |
| VP & Head of Regulatory Affairs | 5.1yrs | データなし | データなし |
5.9yrs
平均在職期間
58yo
平均年齢
経験豊富な経営陣: 1LV's management team is seasoned and experienced (5.9 years average tenure).
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 6.9yrs | US$1.91m | 0.94% $ 317.2k | |
| Independent Director | 2.9yrs | US$132.08k | 0% $ 0 | |
| Independent Director | 5.8yrs | US$131.58k | 0% $ 0 | |
| Independent Chairman of the Board | 6.5yrs | US$160.08k | 0% $ 0 | |
| Independent Director | 6.5yrs | US$120.58k | 0% $ 0 | |
| Independent Director | 1.7yrs | US$124.58k | 0% $ 0 | |
| Independent Director | 7yrs | US$124.08k | 0% $ 0 | |
| Independent Director | 4.1yrs | US$132.08k | 0% $ 0 | |
| Independent Director | 5.7yrs | US$126.08k | 0% $ 0 |
5.8yrs
平均在職期間
59yo
平均年齢
経験豊富なボード: 1LV's board of directors are considered experienced (5.8 years average tenure).